个人中心 - 老虎社区

需要技术支持吗

IP属地：湖北

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 需要技术支持吗需要技术支持吗
  ·2020-09-11
  乐普的其他收入就不算了，真是可以
  半年五次增持微创医疗，高瓴资本再斥7亿加码旗下子公司！
  半年之内，高瓴资本连续增持微创医疗，两次加仓母公司、三次投资旗下子公司，如此高频投资一家公司，可谓罕见。标签：微创医疗高瓴资本增持近日，高瓴资本在医疗领域又有新动作：斥资7.74亿元认购了微创医疗旗下
  半年五次增持微创医疗，高瓴资本再斥7亿加码旗下子公司！
  3,142 评论
  点赞
  分享
  举报
- 需要技术支持吗需要技术支持吗
  ·2020-05-27
  $信也科技(FINV)$小平台退出，不是利好吗，你们爱买不买
  2,072 评论
  1
  分享
  举报
- 需要技术支持吗需要技术支持吗
  ·2020-05-27
  $现代牙科(03600)$继续涨，这股要放大A，早就上天了
  3,649 1
  1
  分享
  举报
- 需要技术支持吗需要技术支持吗
  ·2020-05-27
  $信也科技(FINV)$今天你爱答不理，明天还是爱答不理
  3,433 1
  1
  分享
  举报
- 需要技术支持吗需要技术支持吗
  ·2020-05-02
  $信也科技(FINV)$我的分红到了，一季报会不会有雷，只要一季报没太大问题就能证明公司平稳着陆了
  2,664 1
  1
  分享
  举报
- 需要技术支持吗需要技术支持吗
  ·2020-04-29
  $信也科技(FINV)$养一堆银行，贷款全进房地产和国企，不如一个p2p公司支持小微企业，要你们何用？
  5,405 1
  2
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3498617933168263","uuid":"3498617933168263","gmtCreate":1546614273818,"gmtModify":1546614273818,"name":"需要技术支持吗","pinyin":"xyjszcmxuyaojishuzhichima","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":32,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.02%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.63%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"湖北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":976420798,"gmtCreate":1599822184514,"gmtModify":1703819826268,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"乐普的其他收入就不算了，真是可以","listText":"乐普的其他收入就不算了，真是可以","text":"乐普的其他收入就不算了，真是可以","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/976420798","repostId":"2066271799","repostType":2,"repost":{"id":"2066271799","kind":"news","pubTimestamp":1599795480,"share":"https://www.laohu8.com/m/news/2066271799?lang=zh_CN&edition=full","pubTime":"2020-09-11 11:38","market":"hk","language":"zh","title":"半年五次增持微创医疗，高瓴资本再斥7亿加码旗下子公司！","url":"https://stock-news.laohu8.com/highlight/detail?id=2066271799","media":"环球老虎财经","summary":"半年之内，高瓴资本连续增持微创医疗，两次加仓母公司、三次投资旗下子公司，如此高频投资一家公司，可谓罕见。标签：微创医疗高瓴资本增持近日，高瓴资本在医疗领域又有新动作：斥资7.74亿元认购了微创医疗旗下","content":"<html><body><article><img src=\"https://fid-75186.picgzc.qpic.cn/20200911113828591v246nu7cisqozvx\"/><p>半年之内，高瓴资本连续增持<a href=\"https://laohu8.com/S/00853\">微创医疗</a>，两次加仓母公司、三次投资旗下子公司，如此高频投资一家公司，可谓罕见。</p><img src=\"https://fid-75186.picgzc.qpic.cn/20200911113830067v246ax12n4401ly\"/><p>标签：微创医疗高瓴资本增持</p><p>近日，高瓴资本在医疗领域又有新动作：<strong>斥资7.74亿元认购了微创医疗旗下手术<a href=\"https://laohu8.com/S/300024\">机器人</a>公司3.35%股权。这也是今年以来，高瓴资本对微创医疗进行的第五次增持行动。</strong></p><p>今年3月，高瓴资本斥资约6.45亿港元加仓微创医疗4773.4万股，持股比例升至6.61%。高瓴增持以来，微创医疗股价一改横盘状态，节节攀升，从3月初的10港元/股最高飙涨到45港元的历史峰值。</p><p>随后，高瓴资本又参与了微创医疗6月份的定增项目。6月23日，微创医疗公告称，按每股23.5港元增发6595.8万股，高瓴资本出资7.7亿港元拿下其中一半。</p><p><strong>除了对母公司微创医疗的直接加仓，今年以来高瓴资本还多次出手投资微创医疗旗下子公司。</strong></p><p>4月16日，微创医疗旗下微创心通公司以投前估值11亿美元完成新一轮融资，引入包括高瓴资本在内的7家知名战略投资者，融资金额达1.3亿美元。</p><p>7月份，微创医疗再发公告称，旗下专注于提供诊断、治疗和管理心律失常和心力衰竭解决方案的子公司微创心律管理有限公司进行B轮定增，融资金额达1.05亿美元，其中高瓴资本认购一半，所占股权比例为达12.46%。</p><p><strong>加上最新对微创机器人的投资，高瓴资本年内已经三次投资微创医疗旗下子公司。</strong></p><p>得到高瓴资本的连续增持，微创医疗究竟有何魅力？</p><p>资料显示，微创医疗创立于1998年，是一家创新型高端医疗器械公司。2010年，微创医疗在港交所挂牌上市。2019年，微创医疗下属从事主动脉及外周血管介入医疗器械业务的<a href=\"https://laohu8.com/S/688016\">心脉医疗</a>作为首批25家科创板上市公司之一，登陆科创板。</p><p>截至2019年底，公司共拥有心血管介入产品、骨科医疗器械等八个主要业务分部，共生产300多个医疗器械产品，其中在心血管高值耗材领域处于行业主导地位。<strong>2019年财报显示，公司去年实现总营收7.93亿美元（约合人民币55亿元），同比增长18.5%，且收入全部来自医疗器械，其中血管用器械业务占营收比重为43%。</strong></p><p>同期，另一心血管介入器械龙头<a href=\"https://laohu8.com/S/300003\">乐普医疗</a>的器械板块收入为36.2亿元，在营收规模上不敌微创医疗。</p><p><strong>不过今年上半年，微创医疗业绩表现不佳，自2014年来中期业绩首次由盈转亏。</strong>根据微创医疗披露的中报，2020年上半年录得净亏损6880万美元，去年同期则实现净利润约6550万美元。</p><p>对此微创表示，利润下滑主要系受疫情影响，以及报告期内未有上年同期处置上海微创电生理医疗科技股份有限公司部分股权获取的一次性投资收益。去年6月，微创医疗完成对部分微创电生理股份的转让交割，持股降至45.1%，通过出售股份，微创医疗录得一次性收益约为5600万美元。</p><p>如需转载请与上海鸣应信息技术有限公司联系。未经上海鸣应信息技术有限公司授权，严禁转载或镜像，违者必究。版权合作及网站合作电话：021-80316510<strong>您可能感兴趣的文章</strong></p><p>急推“多等5分钟”功能，饿了么“偷鸡不成蚀把米”</p><p>释放不超过49.5%股权！南航货运混改开启</p><p>跑路风险大？相互宝、水滴互助纷纷回应</p><p>踩“三道红线”却被惠誉看好，<a href=\"https://laohu8.com/S/000671\">阳光城</a>放量涨停</p><p><a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>叫停疫苗试验，千亿牛股<a href=\"https://laohu8.com/S/300601\">康泰生物</a>上演高台跳水！</p><p>妖股乱舞，<a href=\"https://laohu8.com/S/300313\">天山生物</a>等3股遭集体停牌！</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>半年五次增持微创医疗，高瓴资本再斥7亿加码旗下子公司！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n半年五次增持微创医疗，高瓴资本再斥7亿加码旗下子公司！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-09-11 11:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009111138307a17c35f&s=b><strong>环球老虎财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>半年之内，高瓴资本连续增持微创医疗，两次加仓母公司、三次投资旗下子公司，如此高频投资一家公司，可谓罕见。标签：微创医疗高瓴资本增持近日，高瓴资本在医疗领域又有新动作：斥资7.74亿元认购了微创医疗旗下手术机器人公司3.35%股权。这也是今年以来，高瓴资本对微创医疗进行的第五次增持行动。今年3月，高瓴资本斥资约6.45亿港元加仓微创医疗4773.4万股，持股比例升至6.61%。高瓴增持以来，微创医疗...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009111138307a17c35f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/98e661d079a394a2795b91495bc103d7","relate_stocks":{"00853":"微创医疗"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202009111138307a17c35f&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2066271799","content_text":"半年之内，高瓴资本连续增持微创医疗，两次加仓母公司、三次投资旗下子公司，如此高频投资一家公司，可谓罕见。标签：微创医疗高瓴资本增持近日，高瓴资本在医疗领域又有新动作：斥资7.74亿元认购了微创医疗旗下手术机器人公司3.35%股权。这也是今年以来，高瓴资本对微创医疗进行的第五次增持行动。今年3月，高瓴资本斥资约6.45亿港元加仓微创医疗4773.4万股，持股比例升至6.61%。高瓴增持以来，微创医疗股价一改横盘状态，节节攀升，从3月初的10港元/股最高飙涨到45港元的历史峰值。随后，高瓴资本又参与了微创医疗6月份的定增项目。6月23日，微创医疗公告称，按每股23.5港元增发6595.8万股，高瓴资本出资7.7亿港元拿下其中一半。除了对母公司微创医疗的直接加仓，今年以来高瓴资本还多次出手投资微创医疗旗下子公司。4月16日，微创医疗旗下微创心通公司以投前估值11亿美元完成新一轮融资，引入包括高瓴资本在内的7家知名战略投资者，融资金额达1.3亿美元。7月份，微创医疗再发公告称，旗下专注于提供诊断、治疗和管理心律失常和心力衰竭解决方案的子公司微创心律管理有限公司进行B轮定增，融资金额达1.05亿美元，其中高瓴资本认购一半，所占股权比例为达12.46%。加上最新对微创机器人的投资，高瓴资本年内已经三次投资微创医疗旗下子公司。得到高瓴资本的连续增持，微创医疗究竟有何魅力？资料显示，微创医疗创立于1998年，是一家创新型高端医疗器械公司。2010年，微创医疗在港交所挂牌上市。2019年，微创医疗下属从事主动脉及外周血管介入医疗器械业务的心脉医疗作为首批25家科创板上市公司之一，登陆科创板。截至2019年底，公司共拥有心血管介入产品、骨科医疗器械等八个主要业务分部，共生产300多个医疗器械产品，其中在心血管高值耗材领域处于行业主导地位。2019年财报显示，公司去年实现总营收7.93亿美元（约合人民币55亿元），同比增长18.5%，且收入全部来自医疗器械，其中血管用器械业务占营收比重为43%。同期，另一心血管介入器械龙头乐普医疗的器械板块收入为36.2亿元，在营收规模上不敌微创医疗。不过今年上半年，微创医疗业绩表现不佳，自2014年来中期业绩首次由盈转亏。根据微创医疗披露的中报，2020年上半年录得净亏损6880万美元，去年同期则实现净利润约6550万美元。对此微创表示，利润下滑主要系受疫情影响，以及报告期内未有上年同期处置上海微创电生理医疗科技股份有限公司部分股权获取的一次性投资收益。去年6月，微创医疗完成对部分微创电生理股份的转让交割，持股降至45.1%，通过出售股份，微创医疗录得一次性收益约为5600万美元。如需转载请与上海鸣应信息技术有限公司联系。未经上海鸣应信息技术有限公司授权，严禁转载或镜像，违者必究。版权合作及网站合作电话：021-80316510您可能感兴趣的文章急推“多等5分钟”功能，饿了么“偷鸡不成蚀把米”释放不超过49.5%股权！南航货运混改开启跑路风险大？相互宝、水滴互助纷纷回应踩“三道红线”却被惠誉看好，阳光城放量涨停阿斯利康叫停疫苗试验，千亿牛股康泰生物上演高台跳水！妖股乱舞，天山生物等3股遭集体停牌！","news_type":1,"symbols_score_info":{"00853":1}},"isVote":1,"tweetType":1,"viewCount":3142,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":951034852,"gmtCreate":1590585520276,"gmtModify":1704192992740,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>小平台退出，不是利好吗，你们爱买不买","listText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>小平台退出，不是利好吗，你们爱买不买","text":"$信也科技(FINV)$小平台退出，不是利好吗，你们爱买不买","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/951034852","isVote":1,"tweetType":1,"viewCount":2072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":951034047,"gmtCreate":1590585440889,"gmtModify":1704192992399,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/03600\">$现代牙科(03600)$</a>继续涨，这股要放大A，早就上天了","listText":"<a href=\"https://laohu8.com/S/03600\">$现代牙科(03600)$</a>继续涨，这股要放大A，早就上天了","text":"$现代牙科(03600)$继续涨，这股要放大A，早就上天了","images":[{"img":"https://static.tigerbbs.com/52b09ad2149616cd9b92f62652db9cec","width":"1080","height":"1371"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/951034047","isVote":1,"tweetType":1,"viewCount":3649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":951035063,"gmtCreate":1590585267552,"gmtModify":1704192991543,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>今天你爱答不理，明天还是爱答不理","listText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>今天你爱答不理，明天还是爱答不理","text":"$信也科技(FINV)$今天你爱答不理，明天还是爱答不理","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/951035063","isVote":1,"tweetType":1,"viewCount":3433,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":924268607,"gmtCreate":1588350290109,"gmtModify":1704367542875,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>我的分红到了，一季报会不会有雷，只要一季报没太大问题就能证明公司平稳着陆了","listText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>我的分红到了，一季报会不会有雷，只要一季报没太大问题就能证明公司平稳着陆了","text":"$信也科技(FINV)$我的分红到了，一季报会不会有雷，只要一季报没太大问题就能证明公司平稳着陆了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/924268607","isVote":1,"tweetType":1,"viewCount":2664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":924040677,"gmtCreate":1588170360899,"gmtModify":1704366763964,"author":{"id":"3498617933168263","authorId":"3498617933168263","name":"需要技术支持吗","avatar":"https://static.tigerbbs.com/dc22d188262605499c01439fef83a79e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3498617933168263","idStr":"3498617933168263"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>养一堆银行，贷款全进房地产和国企，不如一个p2p公司支持小微企业，要你们何用？","listText":"<a href=\"https://laohu8.com/S/FINV\">$信也科技(FINV)$</a>养一堆银行，贷款全进房地产和国企，不如一个p2p公司支持小微企业，要你们何用？","text":"$信也科技(FINV)$养一堆银行，贷款全进房地产和国企，不如一个p2p公司支持小微企业，要你们何用？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/924040677","isVote":1,"tweetType":1,"viewCount":5405,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3527667803686145","idStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心！如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}